Eph Antibodies

Santa Cruz Biotechnology delivers a wide array of Eph Antibodies for advanced research in cell signaling and development. Eph Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Eph receptors and ephrin ligands mediate cell-cell interactions, influencing neuronal development, angiogenesis, and tissue homeostasis. Research has shown that altered Eph signaling contributes to various diseases, including cancer. Understanding the molecular mechanisms of Eph receptors advances knowledge in cellular communication and disease progression. Investigating Eph signaling pathways reveals potential therapeutic targets for cancer treatment. Exploring the relationship between Eph receptors and their binding partners provides insights into developmental processes. Characterizing Eph receptor expression patterns helps identify their roles in specific tissues and organs. Santa Cruz Biotechnology monoclonal antibodies for Eph research support scientists worldwide in advancing cellular biology and disease treatment strategies.